Cresco Capital Partners, a NYC-based private equity firm focused on the legal cannabis industry, closed $60m for its second fund.
CCP Fund II has already deployed approximately $22m to date from Fund II in 15 companies that operate across the cannabis supply chain, from genetics and breeding, to retail branding and distribution.
Its diverse portfolio includes companies such as Harborside/FLRish Inc., MJ Freeway, PROHBTD, NorCal Cannabis Company, Sunderstorm, Phylos Biosciences, Sublime, Cellibre, among others.
Led by Matthew Hawkins, Managing Principal, Cresco Capital Partners is a private equity investment firm focused solely on making strategic investments in the legal cannabis market. Since inception in 2014, the firm has raised more than $85m in its two funds as well as a series of co-investments and has achieved seven exits across its two existing funds including major companies such as Acreage, Green Thumb Industries (GTI), Ebbu and Form Factory.